M. Alexander Otto began his reporting career early in 1999 covering the pharmaceutical industry for a national pharmacists' magazine and freelancing for the Washington Post and other newspapers. He then joined BNA, now part of Bloomberg News, covering health law and the protection of people and animals in medical research. Alex next worked for the McClatchy Company. Based on his work, Alex won a year-long Knight Science Journalism Fellowship to MIT in 2008-2009. He joined the company shortly thereafter. Alex has a newspaper journalism degree from Syracuse (N.Y.) University and a master's degree in medical science -- a physician assistant degree -- from George Washington University. Alex is based in Seattle.
News
Shorter time to metastases associated with worse RCC outcomes
- Author:
- M. Alexander Otto
Synchronous disease a distinct molecular phenotype?
Article
Lorcaserin withdrawn from U.S. market due to cancer risk
- Author:
- M. Alexander Otto
The Food and Drug Administration advised health care professionals to stop prescribing and dispensing lorcaserin and to contact patients who are...
News
Nonspecific musculoskeletal symptoms might indicate early PsA
- Author:
- M. Alexander Otto
Diagnosis may be delayed more than 5 years.
News
Lidocaine-prilocaine cream tops lidocaine injections for vulvar biopsy pain
- Author:
- M. Alexander Otto
Studies have pitted the cream against the injection before, but they did not compare patients’ maximal pain scores.
News
Fewer complications, better outcomes with outpatient UKA
- Author:
- M. Alexander Otto
“In carefully selected patients, the ambulatory surgery center seems to be a safe alternative to the inpatient hospital setting.”
News
CRISPR-engineered T cells may be safe for cancer, but do they work?
- Author:
- M. Alexander Otto
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
News
Staged hemispheric embolization: How to treat hemimegalencephaly within days of birth
- Author:
- M. Alexander Otto
“Neurosurgeons won’t touch them.”
News
RCT confirms CT scan screening catches lung cancer early
- Author:
- M. Alexander Otto
CT screening of older people with heavy smoking histories – using lesion volume, not diameter, as a trigger for further work-up – reduced lung...
News
Serum keratin 18 promising as AAH biomarker
- Author:
- M. Alexander Otto
There is a stronger association between serum level of keratin 18 and amount of hepatocyte death and liver disease severity than for other...
News
Wuhan virus: What clinicians need to know
- Author:
- M. Alexander Otto
“It’s not good enough to just download CDC’s guidance; use it to make your own local plan and know what to do 24/7.”
News
Exogenous boosting against shingles not as robust as thought
- Author:
- M. Alexander Otto
U.K. investigators perform a study to try to solve a varicella vaccine debate on whether pediatric vaccination is indicated.
News
Hippocampal sparing temporal lobectomy recommended for medically refractory epilepsy
- Author:
- M. Alexander Otto
BALTIMORE – Hippocampal sparing anterior temporal lobectomy reduced the risk of memory impairment in patients with intractable temporal lobe...
News
Cognitive screening of older physicians: What’s fair?
- Author:
- M. Alexander Otto
A new report leads to questions about how to standardize the process rather than have a piecemeal institutional approach and whether to focus less...
News
Draft ACR Takayasu’s guidelines: Surgery is the last resort
- Author:
- M. Alexander Otto
ATLANTA – One of the goals in soon-to-be-published Takayasu’s arteritis guidelines from the American College of...
News
Prednisolone scores for hand OA
- Author:
- M. Alexander Otto
ATLANTA – The approach “is for short course. Long-term steroids can have important side effects, like osteoporosis. We do not think this study...